Director/PDMR Shareholding

RNS Number : 8282B
Advanced Medical Solutions Grp PLC
06 April 2017


 

5 April 2017

  Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

  Director/PDMR and PCA Shareholding

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that it was notified on 4 April 2017 that on the same day, Chris Meredith, who is a Director and PDMR, had transferred 5,900 Ordinary Shares of 5p held in the name of Platform Securities Nominees Limited (“Nominee”) to a self-invested personal pension (“SIPP”) held in his name.

 

The Company was also informed at the same time, that on 4 April 2017 Chris Meredith had transferred 4,780 Ordinary Shares of 5p held in the name of the Nominee to an Individual Savings Account (“ISA”) held in the name of Ingrid Meredith, the wife of Chris Meredith. The number of shares held by Chris Meredith and the beneficial ownership of the shares remains unchanged. Both transactions are part of normalised tax planning. The transfers are summarised below:

 

 

Director

Number of Ordinary Shares sold from Nominee

Price per Ordinary Share sold

Number of Ordinary Shares purchased by SIPP

Price paid per Ordinary Share by SIPP

Number of Ordinary Shares purchased by ISA

Price paid per Ordinary Share by ISA

Chris Meredith

5,900

249.25p

5,900

249.50p

Chris Meredith

4,780

249.25p

4,780

249.50p

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Chris Meredith

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Transfer of 5,900 Ordinary Shares of 5p held in the name the Nominee to a SIPP held in the name of Chris Meredith

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

Sale of shares from Nominee holding at 249.25p per share

5,900

Purchase by SIPP at 249.50p per share

5,900

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 5,900

Aggregated price: 249.25p

e)

Date of the transaction: 04/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Chris Meredith

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Transfer of 4,780 Ordinary Shares of 5p held in the name the Nominee to an ISA held in the name of Ingrid Meredith

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

Sale of shares from Nominee holding at 249.25p per share

4,780

Purchase by ISA at 249.50p per share

4,780

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 4,780

Aggregated price: 249.25p

e)

Date of the transaction: 04/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

End –

 

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Chief Financial Officer




Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys

AMS@consilium-comms.com



Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb


 

About Advanced Medical Solutions Group plc see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal®, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand® and RESORBA®.

AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 600 employees.  For more information, please see www.admedsol.com.


This information is provided by RNS
The company news service from the London Stock Exchange

END

DSHBDGDSDDGBGRL